John Maskill, 89, decided to walk the Cinder Track after losing his wife to Progressive Supranuclear Palsy (PSP) in March.

Company receives expanded access protocol authorization from the U.S. Food and Drug Administration (FDA) for troculeucel granted to treat patients with known diagnoses of multiple neurodegenerative ...